S&P Futures
3,838.25+29.00(+0.76%)Dow Futures
31,116.00+204.00(+0.66%)Nasdaq Futures
13,036.00+125.00(+0.97%)
AZN Mar 2021 47.500 call
| Previous Close | 2.2000 |
| Open | 2.1200 |
| Bid | 1.5300 |
| Ask | 2.6300 |
| Strike | 47.50 |
| Expire Date | 2021-03-12 |
| Day's Range | 2.1200 - 2.1200 |
| Contract Range | N/A |
| Volume | 1 |
| Open Interest | 8 |
- Reuters
AstraZeneca has sold its stake in Moderna for more than $1 billion -The Times
The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna. AstraZeneca and Moderna did not immediately respond to requests for comment. AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic, the report added.
- Reuters
Taking COVID-19 vaccine will not alter your DNA, Ghana president says
Ghanaian President Nana Akufo-Addo urged citizens of the West African state on Sunday to ignore conspiracy theories surrounding coronavirus vaccines ahead of the launch of its nationwide inoculation campaign against the virus on Tuesday. "Taking the vaccine will not alter your DNA, it will not embed a tracking device in your body, neither will it cause infertility in women or in men," he said. Ghana was the first country to receive vaccines as part of the global COVAX scheme aimed at providing poorer nations vaccines to fight the COVID-19 pandemic.
- PR Newswire
AZN BREAKING NEWS: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline - AZN
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and November 20, 2020, inclusive (the "Class Period"), of the important March 29, 2021 lead plaintiff deadline.
